✦ LIBER ✦

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Scribed by Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald Richards; Svetislava Vukelja; John E. Nugent; Robert L. Ruxer Jr; Kristi A. Boehm; Lina Asmar

Book ID: 119935172
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 144 KB
Volume: 7
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2008.n.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

295 Capecitabine plus irinotecan (CAPIRI

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

✍ A. Grothey; K. Jordan; O. Kellner; C. Constantin; G. Dietrich; H. Kroening; L. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Phase II trial of capecitabine plus cisp

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer

✍ Daniel T. T. Chua; Harry Ho-Yin Yiu; Kasan Seetalarom; Alice Wan-Ying Ng; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Cetuximab and irinotecan as third-line t

Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial

✍ Coppola, R; Beomonte Zobel, B; Trodella, L; Tonini, G; Vincenzi, B; Santini, D; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

3068 POSTER Capecitabine + irinotecan +

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Cetuximab Plus Capecitabine and Irinotec

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group

✍ Moosmann, N.; von Weikersthal, L. F.; Vehling-Kaiser, U.; Stauch, M.; Hass, H. G 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 169 KB

277 Combination of irinotecan and capeci

277 Combination of irinotecan and capecitabine as first line treatment in advanced colorectal cancer (ACC): results of a phase II multicenter trial

✍ C.J.A. Punt; J.W.R. Nortier; W.W. ten Bokkel Huinink; S. Falk; D.J. Richel; T. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB